Search
forLearn
5 / 801 resultslearn plant sterol complex
learn spruce extract
learn GT20029
research compound made to degrade androgen receptors in scalp
learn cannabidiol
Research
5 / 133 resultsresearch Pharmacognostic Standardization of Lawsonia inermis L. Leaf
The research helps standardize Henna leaf for safe use in traditional medicine and hair care.
research Standardisation of Adenostemma lavenia (L.) Kuntze leaves: An unexplored folklore herb from Maharashtra
Adenostemma lavenia leaves have potential as a standardized medicinal herb for hair loss treatment.
research Ayurvedic Hair Science: A Neglected Field in Need of Immediate Research Attention
Ayurvedic hair treatments need scientific research to validate their effectiveness.
research Powder microscopy and phytochemical screening on stem bark and leaves of Buxus wallichiana Baill - Buxaceae
Buxus wallichiana has compounds that support its use in traditional medicine.
research Pharmacognostical Evaluation of Arjuna Flowers
Arjuna flowers have specific features and compounds useful for their identification and standardization.
Community Join
5 / 1000+ resultscommunity Epidemic of brand names working wildly different, if at all.
The conversation discusses the variability in effectiveness of medications, including finasteride, and questions whether different manufacturers impact results. The user suggests sharing successful brands to help others identify effective options.
community Aiming to Standardize RU58841
The conversation discusses the use of RU58841 for hair loss, focusing on its side effects, standardization issues, and user experiences. The user also inquires about the use of other treatments like minoxidil, finasteride, and microneedling.
community Help labing up hair preservations
The conversation is about making RU58841 solutions for hair loss treatment and sourcing ingredients for KB solutions. The user mentions using RU58841 powder from Shaanxi Greenyobiotech.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community Estimate of GT20029 on the grey market?
The conversation is about when GT20029, a hair loss treatment, might be available on the grey market, with users discussing the challenges of compounding it and speculating it might be available after phase 2 results, similar to pyri. Specific treatments mentioned are pyri, RU58841, and GT20029.